United States: Employee Benefits Update - February 2013

SELECT COMPLIANCE DEADLINES AND REMINDERS

Cycle C Submission Period Opened February 1, 2013

Effective February 1, 2013, the Internal Revenue Service (IRS) began accepting determination letter applications from remedial amendment period Cycle C individually designed plans. In general, Cycle C plans must be submitted for a determination letter no later than January 31, 2014 to rely on the extended period during which qualification amendments may be retroactively adopted. Cycle C plans include those sponsored by employers with EINs ending in a "3" or an "8".

Annual Funding Notice Due April 30, 2013

All defined benefit plans must provide the 2012 Annual Funding Notice to plan participants, beneficiaries, labor organizations representing participants and beneficiaries (if applicable), contributing employers and the Pension Benefit Guarantee Corporation (PBGC) (if the plan has more than 100 participants) no later than April 30, 2013.

New Business Associate Agreements Must Comply with New HIPAA Regulations by September 23, 2013

All business associate agreements entered into after January 25, 2013 must comply with newly issued Health Insurance Portability and Accountability Act (HIPAA) regulations by September 23, 2013. For more information regarding changes required to business associate agreements, please see our expanded HIPAA guidance section below.

RETIREMENT PLAN DEVELOPMENTS

PBGC Releases Update Addressing Waivers and Missed Contributions

On January 30, 2013, the PBGC issued Technical Update 13-1 (the Update.) The Update addresses interim guidance regarding funding-related determinations for purposes of waivers, extensions and the advanced threshold test as well as the small-plan waiver for missed quarterly contributions. In general, the Update provides that, for plan years beginning after 2012, a plan's unfunded vested benefits and the value of its assets and vested benefits are determined in the same manner as for variable-rate premiums for the preceding plan year. Additionally, the Update provides that for plan years beginning after 2012, the section 4043.25 reporting requirement for missed quarterly contributions is waived if the contribution was missed for reasons other than financial inability to make the contribution and either (1) the plan had fewer than 25 participants for the preceding plan year, or (2) the plan had between 25 and 100 participants during the preceding plan year and a simplified notice is filed with PBGC by the time the first missed quarterly reportable event report not timely made for the current year would otherwise be due.

IRS Releases New Rules for Correcting Plan Errors Through EPCRS

The IRS has released Revenue Procedure 2013-12 updating the Employee Plans Compliance Resolution System (EPCRS). Changes to the EPCRS program clarify and streamline the correction for many operational and plan document errors. Additionally, the IRS has released standardized forms for use in submitting plan corrections. The changes to EPCRS take effect on April 1, 2013. However, plan sponsors are able to begin using the new forms immediately, if desired.

HEALTH AND WELFARE PLAN DEVELOPMENTS

HHS Issues Updated Regulations Under HIPAA and HITECH

On January 25, 2013, the Department of Health and Human Services (HHS) released final regulations implementing provisions of the Health Insurance Technology for Economic and Clinical Health Act (HITECH) under HIPAA. Covered entities generally must comply with the new rules by September 23, 2013. As discussed in more detail below, covered entities should begin the process of making changes to comply with the new rules, including:

  • Updating their HIPAA policies and procedures;
  • Updating their existing Notice of Privacy Practices;
  • Updating existing business associate agreements. There is a transition rule extending the deadline to update existing business associate agreements (meaning executed before January 23, 2013) to September 23, 2014;
  • Reviewing whether a business associate agreement is now required with entities not previously considered business associates; and
  • Revising notice requirements in privacy, security and breach notification procedures.

Business Associates. The final regulations expand the definition of "business associate" to include any entity that creates, receives, maintains or transmits protected health information (PHI) on behalf of a covered entity or an organized health care arrangement. Specifically, the new definition includes health information organizations, e-prescription gateways, entities that provide data transmission services and require routine access to the PHI, and persons offering personal health records to individuals on behalf of covered entities. Importantly, the new rule maintains the proposed rule's extension of "business associate" to downstream subcontractors of any business associate. As with the earlier proposed rule, the final rule maintains the "conduit" exception for entities that merely transport PHI, but do not have access to PHI on a regular basis.

The final regulations also finalize rules for making business associates directly liable for HIPAA compliance and incorporate the increased and tiered civil penalty structure adopted by HITECH. However, the rule also clarifies that a covered entity will be liable for a business associate's breach if the business associate was acting as agent for the covered entity.

Notification of Breach. The new rules expand the definition of "breach" to clarify that an impermissible use or disclosure of PHI is assumed to be a breach unless the disclosing entity demonstrates that there is a low probability that PHI has been compromised or that an exception applies. Additionally, the new rules remove the actual harm standard, focusing instead on the mere risk that PHI has been compromised. Finally, the new rules remove the exception for limited data sets that do not include dates of birth and ZIP codes; the use or disclosure of any limited data set could trigger notification. The impact of these changes means that covered entities may encounter more situations for which a notice is required.

Factors to consider when making a determination whether to provide notification include:

  • The nature and extent of the PHI involved, including the types of identifiers and the possibility that an individual could be re-identified;
  • The identity of the person or entity who made the unauthorized disclosure or to whom the disclosure was made;
  • Whether PHI was actually acquired or viewed;
  • The extent to which the risk to PHI has been mitigated; and
  • Other appropriate factors, where necessary.

Access to PHI. The new regulations grant individuals new rights relating to PHI. Individuals have a greater ability to restrict uses and disclosure of PHI. For example, covered entities may not disclose information to health insurers if the patient pays for the treatment and requests that the information not be disclosed to insurers. Additionally, a covered entity that maintains PHI in electronic format must make that PHI available to a requesting individual in the electronic format and form requested by the individual. If individuals request their PHI be sent to another person, the covered entity must comply if the request is in writing, signed by the individual and identifies the designate person and where to send the PHI. Finally, a covered entity must produce the requested PHI, or give reason why it cannot produce the PHI, within 30 days of the request, even if the PHI is not maintained on-site.

The new rules also make it easier for family members to obtain information about decedents. The rule also clarifies that HIPAA ceases to apply to information 50 years after the decedent's death.

Notice of Privacy Practices. The final regulations amend the content requirements for a Notice of Privacy Practices. Specifically, the Notice must now include:

  • A statement that most uses and disclosures of: (1) psychotherapy notes (if the covered entity records or maintains psychotherapy notes); (2) PHI for marketing purposes; and (3) PHI for reasons other than those described in the Notice, require an individual's authorization and that such authorization may be revoked.
  • A statement that PHI disclosed for underwriting purposes will not include PHI that is genetic information about an individual for such purposes.
  • A statement describing an individual's right to be notified following a breach of unsecured PHI.

Covered entities are required to inform individuals of these changes because HHS specifically identified the changes as material. If the covered entity is a health plan that posts its notice on its website, the covered entity must prominently post notice of the change to, or a copy of, the notice on its website by the effective date of the change. The covered entity must also provide a copy of the revised notice, or information about the change and instructions on how to receive a copy of the revised notice, in the annual mailing following the effective date of the change. If the covered entity does not post its notice to its website, the covered entity must provide a copy of the revised notice, or information about the change and instructions on how to request a copy of the revised notice, to individuals within 60 days of the change.

Finally, the new rules include privacy protections implementing the provisions of the Genetic Information Nondiscrimination Act (GINA). The HIPAA definition of "health information" now includes "genetic information, whether oral or recorded in any form or medium" to the extent that such information is individually identifiable and held by an entity covered under HIPAA. The result of this expansion is the prohibition of the use or disclosure of genetic information for underwriting purposes. Importantly, the rules contain a temporary exception for long-term care insurance coverage allowing such entities to use genetic information for underwriting purposes.

HHS Issues Proposed Regulations Regarding Verification of Employee Eligibility for Advance Tax Credit and Employers' Limited Appeal Rights

On January 14, 2013, HHS issued proposed regulations clarifying the process by which exchanges will verify an employee's eligibility for advance payment of the premium tax credit and the process through which employers will be able to dispute an exchange's determination. This process means that employers will generally not learn of an employee's eligibility until after the exchange approves the credit. Because employee qualification for the advance credit may trigger an employer penalty under the Patient Protection and Affordable Care Actʼs (PPACA) shared responsibility provisions, employers should work with legal counsel to develop a procedure for reviewing notifications and, where appropriate, appealing eligibility determinations.

Under PPACA, some employees will be eligible for an advance tax credit when purchasing health care coverage through an exchange if they are not eligible for or enrolled in employer-sponsored coverage. Upon applying to the exchange for the advance payment of the credit, employees will be required to provide certain information regarding their access to and the affordability of employer-sponsored coverage. The exchange will then attempt to verify the eligibility information; importantly, the exchange is not required to contact the employer to confirm the employee's eligibility. The employer will then receive notification from the exchange of the final eligibility determination.

Under the proposed regulations, an employer can dispute an exchange's determination that the applying employee is eligible for the payment of the advance credit. The employer may request an appeal from the exchange within 90 days from the date of notice of an employee's eligibility of advance payment of the premium tax credit or cost-sharing reduction. Additionally, employers would be able to submit relevant evidence to the exchange to support their appeal request. Notably, however, employers may not appeal directly to HHS.

Departments Release Additional PPACA Frequently Asked Questions

On January 24, 2013, the Department of Labor (DOL), HHS and the IRS jointly released a new list of frequently asked questions (FAQs) in the series FAQs About Affordable Care Act Implementation. The following answers are of note:

  • Exchange Notice. Employers were required to give employees written notice regarding health care exchanges by March 1, 2013. The due date of this notice has now been delayed. Although no specific alternative date has been given, the DOL expects that the distribution date will be sometime in late summer or fall of 2013.
  • Integrated HRAs Exempt From Limits. Only integrated Health Reimbursement Arrangements (HRA) are exempt from the prohibition on annual and lifetime limits. An integrated HRA is one that requires employees to enroll in primary group health coverage to be eligible for the HRA. The FAQ clarifies that:
    • An HRA that is used to purchase coverage on an exchange or to purchase employer-provided individual coverage is not considered an integrated HRA.
    • An HRA that is offered to employees who refuse coverage that would result in the HRA being an integrated HRA will not be considered an integrated HRA.
    • Unused amounts in an HRA credited prior to January 1, 2014 may be used after December 31, 2013 to reimburse medical expenses without causing the HRA to fail to comply.
  • Employer Group Waiver Plans. Pending further guidance, the FAQ clarifies that the Departments will not take enforcement action against Employer Group Waiver Plans (EGWP) providing non-Medicare prescription drug coverage to employees as well as retirees. Non-Medicare prescription drug coverage provided only to retirees in connection with an EGWP is exempt from the requirements of many of the provisions of the Public Health Services Act, ERISA and the PPACA requirements of the Internal Revenue Code. Additionally, supplemental benefits provided only to retirees through an EGWP are excepted benefits (and therefore exempt from the PPACA requirements) if insured under a separate policy, certificate or contract of insurance. Although EGWP rules do not extend these same benefits to EGWPs providing coverage to Medicare-eligible employees, the FAQ clarifies that the Departments will not seek enforcement action against EGWPs that also provide coverage to employees.
  • Fixed Indemnity Insurance. The FAQ clarifies that hospital, or other fixed indemnity insurance, will be considered excepted benefits under a group health plan if: (a) the benefits are provided under a separate policy, certificate or contract of insurance; (b) there is no coordination between the indemnity benefits and any other benefits provided under the same group health plan; and (c) the benefits are paid without regard to whether other benefits are provided for the same event under any group health plan maintained by the employer.
  • PCORI Fees. In the FAQs, the DOL clarified that fees payable to the Patient Centered Outcomes and Research Institute (PCORI) by a self-insured multiemployer plan may generally be paid from plan assets unless the plan document provides otherwise.

GENERAL DEVELOPMENTS

DOL Clarifies Meaning of "Son or Daughter" Under FMLA

Under the Family Medical Leave Act (FMLA), employees are entitled to up to 12 work weeks of unpaid, job-protected leave during a 12-month period to care for an adult son or daughter who is incapable of self-care because of a mental or physical disability. The DOL's Wage and Hour Division issued Administrator's Interpretation No. 2013-1 on January 14, 2013, clarifying the definition of "son or daughter." The Interpretation provides that FMLA leave to care for an adult son or daughter must be available without regard to whether the adult son or daughter became disabled before or after attaining the age of 18.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions